German health data study sheds light on rare heart condition ATTR-CM
NCT ID NCT07494656
First seen Mar 29, 2026 · Last updated May 22, 2026 · Updated 10 times
Summary
This study looks at anonymous health insurance records from Germany to learn more about a rare heart disease called ATTR-CM. Researchers want to see how long people live after diagnosis, how often they are hospitalized, and how common the disease is. No new treatments or visits are involved—just analysis of existing data.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTR-CM (TRANSTHYRETIN AMYLOID CARDIOMYOPATHY) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pfizer
Berlin, 10117, Germany
Conditions
Explore the condition pages connected to this study.